QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.87 (+2.61%)
BABA   86.69 (+2.71%)
AMD   124.23 (+5.34%)
T   15.66 (+1.75%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.13%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
NYSE:HIMS

Hims & Hers Health (HIMS) Stock Forecast, Price & News

$9.20
+0.25 (+2.79%)
(As of 06/6/2023 ET)
Compare
Today's Range
$8.87
▼
$9.21
50-Day Range
$8.81
▼
$12.04
52-Week Range
$3.54
▼
$12.34
Volume
2.42 million shs
Average Volume
3.20 million shs
Market Capitalization
$1.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.91
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Hims & Hers Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
29.5% Upside
$11.91 Price Target
Short Interest
Healthy
16.98% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.03mentions of Hims & Hers Health in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$2.28 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.21) to ($0.10) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.20 out of 5 stars

Medical Sector

311th out of 981 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 6 stocks

See Top Rated MarketRank™ Stocks Here

HIMS stock logo

About Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

HIMS Stock News Headlines

June 1, 2023 | americanbankingnews.com
Hims & Hers Health (NYSE:HIMS) Price Target Cut to $11.00
May 30, 2023 | forbes.com
Hims (ED) Review
June 6, 2023 | Behind the Markets (Ad)
How A.I. Could Make Most 21st Century Diseases EXTINCT
On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...
May 30, 2023 | msn.com
5 Tips for Coping With Getting Laid Off, According to Therapists
May 30, 2023 | markets.businessinsider.com
6 Analysts Have This to Say About Hims & Hers Health
May 30, 2023 | markets.businessinsider.com
Piper Sandler Reaffirms Their Hold Rating on Hims & Hers Health (HIMS)
May 30, 2023 | markets.businessinsider.com
Analyst Expectations for Hims & Hers Health's Future
May 24, 2023 | finance.yahoo.com
Even though Hims & Hers Health (NYSE:HIMS) has lost US$268m market cap in last 7 days, shareholders are still up 169% over 1 year
June 6, 2023 | Legacy Research (Affiliate) (Ad)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
May 22, 2023 | seekingalpha.com
Hims & Hers Stock: The Gift That Keeps On Giving
May 21, 2023 | finance.yahoo.com
HIMS May 2023 7.000 call
May 14, 2023 | americanbankingnews.com
Hims & Hers Health, Inc. (NYSE:HIMS) Receives $12.00 Consensus Price Target from Brokerages
May 13, 2023 | americanbankingnews.com
Hims & Hers Health, Inc. (NYSE:HIMS) Expected to Earn Q3 2023 Earnings of ($0.05) Per Share
May 12, 2023 | americanbankingnews.com
Brokers Issue Forecasts for Hims & Hers Health, Inc.'s Q1 2024 Earnings (NYSE:HIMS)
May 11, 2023 | msn.com
Top Consumer Staples Stocks for May 2023
May 11, 2023 | markets.businessinsider.com
Robert W. Baird Reaffirms Their Hold Rating on Hims & Hers Health (HIMS)
May 11, 2023 | americanbankingnews.com
Hims & Hers Health (NYSE:HIMS) Shares Gap Down Following Insider Selling
May 11, 2023 | americanbankingnews.com
Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) COO Sells 12,966 Shares of Stock
May 11, 2023 | americanbankingnews.com
Bank of America Increases Hims & Hers Health (NYSE:HIMS) Price Target to $15.00
May 10, 2023 | americanbankingnews.com
Hims & Hers Health (NYSE:HIMS) Reaches New 1-Year High Following Better-Than-Expected Earnings
May 10, 2023 | americanbankingnews.com
Hims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird Sells 19,032 Shares
May 10, 2023 | americanbankingnews.com
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $12.00 at Piper Sandler
May 9, 2023 | markets.businessinsider.com
SVB Securities Sticks to Their Hold Rating for Hims & Hers Health (HIMS)
May 9, 2023 | benzinga.com
Hims & Hers Health shares are trading lower despite the company reporting better-than-expected Q1 financial results and raising guidance.
May 9, 2023 | finance.yahoo.com
Q1 2023 Hims & Hers Health Inc Earnings Call
May 9, 2023 | msn.com
Hims & Hers Health: The Record-Breaking Continues
May 9, 2023 | markets.businessinsider.com
Citigroup Remains a Buy on Hims & Hers Health (HIMS)
See More Headlines

HIMS Price History

HIMS Company Calendar

Last Earnings
5/08/2023
Today
6/06/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:HIMS
CUSIP
N/A
CIK
1773751
Web
www.forhims.com
Phone
415-851-0195
Fax
N/A
Employees
398
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.91
High Stock Price Forecast
$18.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
+29.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-65,680,000.00
Net Margins
-9.65%
Pretax Margin
-9.61%
Return on Equity
-18.97%
Return on Assets
-15.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.01
Quick Ratio
3.64

Sales & Book Value

Annual Sales
$526.92 million
Price / Sales
3.65
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.50 per share
Price / Book
6.13

Miscellaneous

Outstanding Shares
209,320,000
Free Float
143,111,000
Market Cap
$1.92 billion
Optionable
Optionable
Beta
0.48

Key Executives

  • Mr. Andrew DudumMr. Andrew Dudum (Age 34)
    Co-Founder, Chairman & CEO
    Comp: $2.18M
  • Ms. Melissa BairdMs. Melissa Baird (Age 45)
    Chief Operations Officer
    Comp: $800.85k
  • Ms. Irene A. Becklund (Age 38)
    Principal Accounting Officer
    Comp: $544.29k
  • Ms. Soleil Teubner Boughton (Age 44)
    Chief Legal Officer & Corp. Sec.
    Comp: $1.19M
  • Dr. Patrick Carroll M.D. (Age 65)
    Chief Medical Officer, Member of Medical Advisory Board & Director
    Comp: $828.1k
  • Mr. Yemi Okupe (Age 37)
    Chief Financial Officer
  • Mr. Brian O'Shaughnessy
    Chief Communications Officer
  • Ms. Amee Parekh
    Sr. VP of HR
  • Mr. Mike Chi
    Chief Growth Officer
  • Mr. Jonathan Spitzer C.F.A.
    Sr. VP of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













HIMS Stock - Frequently Asked Questions

Should I buy or sell Hims & Hers Health stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last twelve months. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HIMS shares.
View HIMS analyst ratings or view top-rated stocks.

What is Hims & Hers Health's stock price forecast for 2023?

9 Wall Street analysts have issued 1-year price objectives for Hims & Hers Health's shares. Their HIMS share price forecasts range from $5.00 to $18.00. On average, they anticipate the company's stock price to reach $11.91 in the next twelve months. This suggests a possible upside of 29.5% from the stock's current price.
View analysts price targets for HIMS or view top-rated stocks among Wall Street analysts.

How have HIMS shares performed in 2023?

Hims & Hers Health's stock was trading at $6.41 at the beginning of 2023. Since then, HIMS stock has increased by 43.4% and is now trading at $9.1950.
View the best growth stocks for 2023 here.

Are investors shorting Hims & Hers Health?

Hims & Hers Health saw a decline in short interest in May. As of May 15th, there was short interest totaling 20,940,000 shares, a decline of 7.0% from the April 30th total of 22,510,000 shares. Based on an average daily trading volume, of 3,860,000 shares, the short-interest ratio is presently 5.4 days. Currently, 17.0% of the company's shares are short sold.
View Hims & Hers Health's Short Interest.

When is Hims & Hers Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our HIMS earnings forecast.

How were Hims & Hers Health's earnings last quarter?

Hims & Hers Health, Inc. (NYSE:HIMS) released its earnings results on Monday, May, 8th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.01. The company had revenue of $190.80 million for the quarter, compared to analyst estimates of $179.07 million. Hims & Hers Health had a negative net margin of 9.65% and a negative trailing twelve-month return on equity of 18.97%. The firm's revenue was up 88.4% compared to the same quarter last year. During the same period last year, the firm earned ($0.08) earnings per share.

What ETFs hold Hims & Hers Health's stock?

ETFs with the largest weight of Hims & Hers Health (NYSE:HIMS) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), First Trust Small Cap Growth AlphaDEX Fund (FYC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), First Trust Small Cap Core AlphaDEX Fund (FYX), iShares Micro-Cap ETF (IWC).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Hims & Hers Health issued on next quarter's earnings?

Hims & Hers Health updated its second quarter 2023 earnings guidance on Monday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $200.00 million-$205.00 million, compared to the consensus revenue estimate of $183.30 million.

What is Hims & Hers Health's stock symbol?

Hims & Hers Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HIMS."

Who are Hims & Hers Health's major shareholders?

Hims & Hers Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.29%), Institutional Venture Management XVI LLC (3.70%), Institutional Venture Management XV LLC (3.70%), Redpoint Management LLC (3.19%), Foresite Capital Management V LLC (1.79%) and State Street Corp (1.42%). Insiders that own company stock include Alex Bard, Andrew Dudum, David B Wells, David B Wells, Irene Becklund, Jack Abraham, Jules A Maltz, Lynne Chou O'keefe, Melissa Baird, Oluyemi Okupe, Patrick Harrison Carroll, Soleil Boughton and Spencer Lee.
View institutional ownership trends.

How do I buy shares of Hims & Hers Health?

Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hims & Hers Health's stock price today?

One share of HIMS stock can currently be purchased for approximately $9.20.

How much money does Hims & Hers Health make?

Hims & Hers Health (NYSE:HIMS) has a market capitalization of $1.92 billion and generates $526.92 million in revenue each year. The company earns $-65,680,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis.

How many employees does Hims & Hers Health have?

The company employs 398 workers across the globe.

How can I contact Hims & Hers Health?

Hims & Hers Health's mailing address is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. The official website for the company is www.forhims.com. The company can be reached via phone at 415-851-0195 or via email at hims-ir@westwicke.com.

This page (NYSE:HIMS) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -